Podcasts about G6

Be careful before you sit! Week 13 may be short on marquee matchups, but with the college football season winding down and so much still in flux, there's more than enough potential for a contender to get bit. In this episode, we preview an eventful slate of games, as Oklahoma looks to seal its playoff bid, USC aims to knock off Oregon, BYU hopes to make the Big 12 title game, and Louisville, SMU, Pitt and Georgia Tech are primed to be the ultimate agents of ACC chaos. Plus, we talk through James Franklin's move to Virginia Tech, Lane Kiffin's tour of LSU and Florida, and the latest batch of CFP rankings and projected brackets. And finally, a collection of awesome G6 games and an important Pat League Lightning Round. Timecodes:0:00 - Intro & Saturday Nicknaming8:13 - James Franklin hired by Virginia Tech20:39 - New CFP Rankings & Brackets32:28 - Missouri vs Oklahoma Preview & Predictions37:59 - Louisville vs SMU Preview & Predictions43:22 - USC vs Oregon Preview & Predictions53:32 - Pitt vs Georgia Tech Preview & Predictions58:48 - BYU vs Cincinnati Preview & Predictions1:03:55 - A Dozen Quickie Previews1:27:47 - Under-the-Radar G6 Games1:30:34 - Window of Opportunity1:32:56 - Pat League Lightning RoundSupport the show!: https://www.patreon.com/solidverbalSee omnystudio.com/listener for privacy information.

Let's relive a wild Week 12 of college football. In this episode, we take a look back at the biggest storylines. Oklahoma knocked off Alabama in Tuscaloosa, giving the Sooners a signature SEC win and putting them in prime position to qualify for the College Football Playoff. Meanwhile, Georgia and Notre Dame padded their CFP cases with dominant wins, while both Texas A&M and Georgia Tech needed second half heroics to survive against conference foes. Plus, Virginia make quick work of Duke and helped clarify the ACC title chase, while the race for the coveted G6 playoff spot got significantly more interesting. We'll go through all the big results you need to know, play your voice messages, hand out Dude Alerts and more! Timecodes:0:00 - Intro4:03 - Oklahoma upsets Alabama13:17 - Texas A&M survives South Carolina24:22 - Georgia beats Texas32:55 - Notre Dame dominates Pitt38:36 - Virginia beats Duke43:13 - USC takes down Iowa48:59 - Other Big Ten Games53:09 - Big 12 Games57:54 - Other SEC Games1:00:18 - Other ACC Games1:05:57 - Week 12 Reverbs1:09:30 - G6 Playoff Contenders1:15:24 - Dude AlertsSupport the show!: https://www.patreon.com/solidverbalSee omnystudio.com/listener for privacy information.

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: It's World Diabetes Day and we have a LOT of news to get to! Daily oral insulin tested to prevent T1D, mothers and sons and a T1D link, stem cell updates, Tandem Android news, Omnipod's workplace campaign and more! Find out how to submit your Community Commercial Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom   Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links:   Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. It's world diabetes day! It is marked every year on 14 November, the birthday of Sir Frederick Banting, who co-discovered insulin along with Charles Best in 1922.   WDD was created in 1991 by International Diabetes Federation (IDF) and the World Health Organization and became an official United Nations Day in 2006 with the passage of United Nations Resolution 61/225. There will be a ton of stuff in your feeds today and that's great! I'm going to keep this to a pretty normal in the news episode.. although I do have my own World Diabetes Day announcement – I want YOUR community commercials. You could have an ad for your event or your blog or your project right here! There's a post on the website explaining it all and I'll come back at the end of the episode and tell you more. XX The Primary Oral Insulin Trial (POInT) is the first large-scale clinical trial to test whether giving at-risk children daily oral insulin could prevent or delay type 1 diabetes (T1D). Conducted by researchers from Helmholtz Munich and the Technical University of Munich across five European countries, the study enrolled more than 1,000 children with a genetic risk for T1D. Results published in The Lancet show that while oral insulin did not prevent the development of islet autoantibodies—an early sign of diabetes—it was safe and well tolerated. Importantly, researchers found that some children who received oral insulin developed diabetes more slowly than those given a placebo, suggesting potential protective effects in certain genetic subgroups.   Further analysis revealed that the response to treatment depended on the child's insulin gene variant. Children with genetic versions that raise diabetes risk appeared to benefit, showing delayed onset of the disease, while those without the risk variant did not. These findings point toward a future of personalized prevention, where genetic screening could help identify which children might benefit most from oral insulin. Researchers will continue following the participants until age 12 to assess long-term effects. The study marks a major milestone in decades of diabetes prevention research, highlighting both the promise and complexity of developing tailored, early interventions against type 1 diabetes. XX Joint US-Chinese research looking at generating new beta cells from stomach cells. Upon turning on the "genetic switch," the human stomach cells were converted to insulin-secreting cells within the mice and resembled pancreatic beta cells with respect to gene and protein expression. Encouragingly, when those experiments were done with diabetic mice, insulin secreted from the transformed human cells helped control blood sugar levels and ameliorated diabetes. The scientists hope that a similar approach can be taken to convert cells from a patient's own stomach into insulin-secreting cells directly within the body. Importantly, additional studies are needed to address if this approach is safe and effective to be used in patients. https://www.technologynetworks.com/cell-science/news/human-stomach-cells-tweaked-to-make-insulin-406694 XX A new study in Nature Metabolism may help explain why children born to mothers with type 1 diabetes are less likely to develop the disease early in life compared to those whose fathers or siblings have it. Researchers looked at nearly 2,000 mothers and their children and found that  kids whose moms have type 1 diabetes show changes in their DNA that may actually help protect them. These aren't genetic mutations, but epigenetic changes — chemical tags that turn certain genes on or off. The study found these changes in genes tied to the immune system and type 1 diabetes risk, suggesting that a mother's condition during pregnancy can shape her child's immune response in a protective way. Scientists identified more than 500 areas of DNA where these changes occurred, many in regions that control how the body's immune system works. Most of the changes appeared to calm down the kind of overactive immune response that leads to type 1 diabetes. Researchers even created a "methylation score" to help measure this protective effect. They say the next step is to confirm these results in more diverse groups and figure out exactly how these DNA changes help prevent early diabetes. https://www.news-medical.net/news/20251110/Maternal-type-1-diabetes-may-protect-children-from-developing-the-disease.aspx XX A new study from Karolinska Institutet and Stockholm University reveals that sons born to mothers with type 1 diabetes may develop early vascular dysfunction—independently of metabolic health. The finding may help shape future strategies to prevent cardiovascular disease early in life.     Children of women with type 1 diabetes are known to be at increased risk of developing cardiovascular diseases. This new study, published in Cell Reports Medicine, is the first to show that the risk is linked to early dysfunction in blood vessel cells in sons, even before any metabolic issues arise. The team is now investigating the long-term effects of maternal diabetes, with a particular focus on why sons seem to be affected earlier than daughters. https://medicalxpress.com/news/2025-11-sons-mothers-diabetes-early-vascular.html XX A new study presented at Kidney Week 2025 has shown that the drug finn-uh-near-own  a nonsteroidal mineralocorticoid-receptor antagonist, significantly reduced albuminuria—a key marker of kidney damage—in people with type 1 diabetes (T1D) and chronic kidney disease (CKD). This is the first major breakthrough for this population in more than 30 years. Researchers found that patients taking finerenone saw a 25% average reduction in albuminuria compared to placebo, an improvement that suggests a lower long-term risk for dialysis or kidney transplant. The phase 3 FINE-ONE trial involved 242 adults with T1D and CKD, and results showed benefits as early as three months. The drug was generally well tolerated, with side effects similar to those seen in patients with type 2 diabetes, though mild hyperkalemia (high potassium levels) was slightly more common. Experts say the findings could change the way doctors treat kidney complications in type 1 diabetes, an area that hasn't seen new therapies since the early 1990s. Currently, treatment options rely on blood pressure and blood sugar management, along with renin-angiotensin system (RAS) inhibitors. Finerenone, which is already approved for type 2 diabetes-related CKD, targets overactivation of a receptor that drives kidney damage. Based on these results, Bayer plans to seek FDA approval in 2026 for use in people with T1D and CKD. Researchers and clinicians alike are calling the study "groundbreaking," noting that it opens the door to future research on how finerenone might not just slow kidney decline—but possibly prevent it altogether. https://www.medscape.com/viewarticle/finerenone-offers-hope-kidney-disease-type-1-diabetes-2025a1000uzi?form=login   XX This week, Tandem Diabetes Care (Nasdaq:TNDM) announced a major milestone for its Mobi miniature durable insulin pump system. San Diego-based Tandem revealed that it received FDA approval for the Android version of its Mobi mobile app. Clearance brings Mobi — which the company describes as the world's smallest, durable automated insulin delivery system — to more users. The pump, which pairs with Tandem's Control-IQ+ algorithm, previously worked with iOS software.   Tandem — one of the largest diabetes tech companies in the world — expects to begin a limited rollout next month, followed by full commercial availability in early 2026. This marks the latest milestone for the company, which continues to expand its offerings and widen its reach within the diabetes patient population.   We had a great interview with Tandem on our previous episode, but as I said at the time, it was coming before their earnings call. So here's an update: The company plans to submit the tubeless mobi to the fda before the end of this year.. possible approval and shipping date is hoped for by middle of 2026. Trials for their fully closed loop next-generation algorithm which we tlkaed abou ton the show should be launched in 2026 The Sigi patch pump will be developed and launched as a next-generation version of the Mobi Great job by Dr. David ? Ahn – he posted on IG after getting a message from tandem CEO John Sheridan? 1. First, the Tandem X3 *is* still absolutely in development, contrary to my speculation In yesterday's video. As many of you appropriately pointed out, there is definitely a market for a 300 unit pump, a pump with a screen, and a pump that does not require smartphone control. So from our brief chat, the sense I got that is that the X3 would be more of a refresh of the X2 with newer components, such as a USB-C connector and better memory, rather than a total redesign from the ground up. In terms of timing, all I could get was that it was "not too far distant in the future," which could mean anything I guess, but at least it's still on the way! 2. Next up, he also reassured me that they are working closely with Dexcom to support the G7 15 Day sensor within the next few months. I suspected as much, but it's always good to hear confirmation. 3. Lastly, he did confirm that Tandem is far along in developing a Caregiver/Follow app to allow the remote viewing of glucose and insulin data from a Tandem pump. He explained that it will be based on Sugarmate, the popular diabetes data dashboard app that Tandem acquired back in Jun 2020. While I don't know if every feature will make it into the Tandem caregiver app, Sugarmate is well-liked for its highly customizable dashboard and highly configurable alerts. Sugarmate even has the option to send a text message or phone call for urgent lows. Regardless, a true follow/Caregiver app will be welcomed with open arms by all caregivers and Tandem users who use Libre 3 Plus. https://time.com/7318020/worlds-top-healthtech-companies-2025/ XX Senseonics submits Eversense 365 – their year long implantable CGM for a CE mark, European Approval and expect to launch there soon. Eversense will be integrated with the sequel twist pump – again I'm hearing soon but no timeline. Intersting to note that one year inseration was approved in the US just about a year ago, so the first patients will be having their CGMs changed out – for the first time – pretty soon. https://www.drugdeliverybusiness.com/senseonics-q2-2025-sales-beat-ce-mark/ XX A confusing study out of Rutgers - these researcher say  metformin reduces some of the key benefits normally gained from regular physical activity. These include improvements in blood vessel health, physical fitness, and the body's ability to regulate blood sugar. Since 2006, doctors have typically encouraged patients with elevated blood sugar levels to combine metformin with exercise, expecting that the two proven treatments would produce stronger results together. However, the new research suggests this may not be the case. In this study, Exercise alone improved vascular insulin sensitivity, meaning blood vessels responded better to insulin and allowed more blood flow to muscles. This matters because insulin's ability to open blood vessels helps shuttle glucose out of the bloodstream and into tissues, lowering blood sugar after meals. But when metformin was added, the improvements shrank. The drug also diminished gains in aerobic fitness and reduced the positive effects on inflammation and fasting glucose. The findings don't mean people should stop taking metformin or exercising, Malin said. Instead, it raises urgent questions for doctors about how the two treatments can be combined and the need for close monitoring. Malin hopes future research will uncover strategies that preserve the benefits of both. https://scitechdaily.com/popular-diabetes-drug-metformin-may-cancel-out-exercise-benefits-study-warns/ XX XX https://www.medtechdive.com/news/Revvity-Sanofi-diabetes-test-Kihealth-seed-round/802133/   XX Dexcom recalled an Android app for its G6 glucose sensor due to a software problem that could cause the app to terminate unexpectedly. The issue could cause users to miss alarms, alerts or notifications related to estimated glucose values, according to a Food and Drug Administration database entry posted Oct. 30. The glucose sensor and the app are still available, but Dexcom required users to update the app to a new version. Dexcom began the recall on Aug. 28. The FDA designated the event as a Class 1 recall, the most serious kind. Dexcom sent a notification to customers in September about the software bug, which applies to version 1.15 of the G6 Android app. To use the app, customers must update it to a new version, according to the entry. https://www.medtechdive.com/news/dexcom-recall-g6-cgm-app/804630/ XX https://www.medscape.com/viewarticle/automated-insulin-delivery-boosts-glycemic-control-youth-2025a1000ub3 XX Tidepool partners with smart ring maker OURA.. press release says: to support a groundbreaking dataset intended to be broadly available for diabetes research, with participation limited to individuals who opt in through Tidepool.         Tidepool will pair biometric data from Oura Ring – sleep, activity, heart rate, temperature trends, and menstrual cycles – with diabetes device data, including continuous glucose monitors (CGMs) and insulin pumps. The result will provide researchers with an unprecedented dataset to accelerate the development of new clinical guidelines, next-generation diabetes technology, and personalized care models.   Recruitment is expected to launch in early 2026 through an IRB-approved study. By opting in to this study, participants consent to sharing their data with Tidepool's Big Data Donation Project, where data is de-identified and, with participant consent, shared with academics, researchers, and industry innovators to accelerate diabetes research. https://aijourn.com/tidepool-collaborates-with-oura-to-advance-inclusive-diabetes-research-through-wearables/ XX Eli Lilly launches two new clinical trials for baricitinib. These phase 3 trials will investigate whether the drug can delay T1D onset or progression and will open for recruitment soon. Baricitinib has the potential to extend the "honeymoon period" of T1D, meaning that it could preserve remaining insulin-producing beta cells earlier in disease progression. More beta cells mean better blood sugar management—and potentially reduced long-term complications. JAK inhibitors, including baricitinib, are already FDA-approved for other autoimmune diseases, such as rheumatoid arthritis, alopecia, and more. JAK signaling pathways are associated with overactive immune responses, so blocking this pathway may turn down the immune response. The phase 2 Breakthrough T1D-funded BANDIT study was key in showing that this drug is safe and effective in T1D. Importantly, baricitinib is a once-daily oral pill—meaning its use is simple and easy.   https://www.breakthrought1d.org/news-and-updates/two-new-trials-baricitinib-to-delay-t1d/ XX   Insulet is taking diabetes awareness into the workplace. Having found 79% of people with diabetes have faced bias or misunderstanding at work, the medtech giant is rolling out a range of resources intended to trigger changes in how workplaces approach the condition. Lots going on for Diabetes Awareness month.. some notables.. Insulet's "The Day Diabetes Showed up to Work" campaign. based on a survey of almost 10,000 people 79% of people with diabetes have faced bias or misunderstanding at work,.   Almost 90% of people with diabetes surveyed reported experiencing barriers at work due to their condition, and more than 40% of people with diabetes and caregivers said they have workplace-related anxiety tied to the metabolic disease. Around one-quarter of respondents reported fears that diabetes could limit opportunities or lead to workplace discrimination and judgment, and a similar proportion of people said they conceal their condition. https://www.fiercepharma.com/marketing/widespread-workplace-challenges-people-diabetes-spark-insulet-campaign XX New directive issued by the Trump administration could mean people seeking visas to live in the U.S. might be rejected if they have certain medical conditions, including diabetes or obesity.   The guidance, issued in a cable the State Department sent to embassy and consular officials and examined by KFF Health News, directs visa officers to deem applicants ineligible to enter the U.S. for several new reasons, including age or the likelihood they might rely on public benefits.   The guidance says that such people could become a "public charge" — a potential drain on U.S. resources — because of their health issues or age.   The cable's language appears at odds with the Foreign Affairs Manual, the State Department's own handbook, which says that visa officers cannot reject an application based on "what if" scenarios, Wheeler said.   The guidance directs visa officers to develop "their own thoughts about what could lead to some sort of medical emergency or sort of medical costs in the future," he said. "That's troubling because they're not medically trained, they have no experience in this area, and they shouldn't be making projections based on their own personal knowledge or bias."   Immigrants already undergo a medical exam by a physician who's been approved by a U.S. embassy. https://www.npr.org/2025/11/12/nx-s1-5606348/immigrants-visas-health-conditions-trump-guidance XX SAN DIEGO---Nov. 14, 2025—DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, today unveiled 16 new diabetes advocates to represent people living with diabetes globally as part of Dexcom's World Diabetes Day campaign. The advocates – ranging from ages six to 68, spanning various types of diabetes, and hailing from four continents and five countries – were selected from 1,000 open call submissions based on their experiences advocating for people with diabetes in their communities. While each person's experience with diabetes is unique, they share a common passion for advocacy – and use of Dexcom's glucose biosensing technology. "Through advocacy, I strive to show others, especially children and newly diagnosed patients, that diabetes is not a limitation but an opportunity to grow stronger, inspire resilience and pursue ambitious goals," said Maria Alejandra Jove Valerio, one of Dexcom's new advocates. "What began as a diagnosis at age seven has grown into a lifelong mission to uplift others." This effort represents the first time Dexcom has sourced voices from the broader diabetes community specifically for its World Diabetes Day campaign, reinforcing Dexcom's history of and commitment to giving real people with diabetes a platform to share their story on a global stage. Through engaging, editorial-style portraits and deeply personal stories, the campaign highlights each advocate's personal experience with diabetes, what misconceptions about diabetes they'd like to dispel and how they want to inspire others with diabetes to discover what they're made of. To prepare for the spotlight, the group of advocates met in Los Angeles for a World Diabetes Day photoshoot which included a surprise visit from Grammy-nominated artist, actor, producer and Dexcom Warrior Lance Bass and author, producer, actress and Stelo*Ambassador Retta. This visit offered the advocates an opportunity to exchange stories and personal perspectives on the meaning of diabetes advocacy and how they live it each day. Behind the lens at the shoot was another member of the diabetes community—photographer Tommy Lundberg who lives with Type 1 diabetes. "Directing this photoshoot was nothing short of inspiring. Each of these advocates has a unique an XX On what would have been the 100th birthday of its visionary founder Alfred E. Mann, MannKind Corporation (Nasdaq: MNKD), in partnership with Alfred E. Mann Charities and The Diabetes Link, announced the launch of the Centennial Al Mann Scholarship. The new program will distribute $100,000 in scholarship funds to support at least 10 young adult students living with diabetes as they pursue higher education in life sciences.   Launched in Diabetes Awareness Month, the scholarship program honors Alfred E. Mann's enduring legacy of innovation, philanthropy, and his lifelong commitment to improving the quality of human life through medical advancement. Deeply passionate about giving back, Mr. Mann believed that his success should continue to serve humanity long after his passing, a belief that lives on through this initiative.   Each scholarship recipient will be awarded up to $10,000, distributed in annual installments of $2,500 throughout the course of their studies. Depending on the length of their degree program, recipients may receive between two and four installments (up to the full $10,000 per student). The first awards will be made for the 2026 academic year.   "Al Mann dedicated his life to helping people with serious medical conditions live longer, healthier lives. This scholarship is a reflection of that spirit," said Michael Castagna, PharmD, Chief Executive Officer of MannKind Corporation. "By supporting students living with diabetes who are pursuing careers in the life sciences and adjacent fields, we're honoring Al's legacy and investing in the future of innovation and care. This program is about giving back to the community we serve and empowering the next generation to carry forward Al's mission of making a meaningful difference in people's lives."   Alfred E. Mann Charities and MannKind will partner with The Diabetes Link to launch the program to serve young adults (aged 18-22) living with either type 1 or type 2 diabetes with their higher education goals. Those eligible will include incoming freshmen and current students pursuing 2- or 4-year degrees. The application window will open in early 2026, and for those interested in receiving notifications, an early interest form is available. More information about the scholarship will be shared on thediabeteslink.org.   "We're honored to partner with MannKind to expand access to higher education for young adults with diabetes," said Manuel Hernández, Chief Executive Officer of The Diabetes Link. "At a time when the cost of college continues to rise, this scholarship helps ease the financial burden and carries forward the spirit of Al Mann, whose vision and legacy continue to inspire us."   Mr. Mann was MannKind's Chairman of the Board from 2001 until his passing in February 2016 and served as Chief Executive Officer from November 2003 until January 2015. Driven by a desire to improve lives and fill unmet medical needs, for more than six decades he founded 17 companies and developed breakthrough medical devices, including insulin pumps, cochlear implants, cardiac pacemakers and retinal prostheses. In 1997, Mr. Mann saw the potential of a dry powder insulin formulation to change the way diabetes is treated and invested nearly $1 billion to help bring Afrezza® (insulin human) Inhalation Powder to market.   About MannKind MannKind Corporation (Nasdaq: MNKD) is a biopharmaceutical company dedicated to transforming chronic disease care through innovative, patient-centric solutions. Focused on cardiometabolic and orphan lung diseases, we develop and commercialize treatments that address serious unmet medical needs, including diabetes, pulmonary hypertension, and fluid overload in heart failure and chronic kidney disease.   With deep expertise in drug-device combinations, MannKind aims to deliver therapies designed to fit seamlessly into daily life.   Learn more at mannkindcorp.com.   About Alfred E. Mann Charities, Inc. Alfred E. Mann Charities, Inc. became active in 2016, following the passing of the organization's benefactor, Alfred E. Mann. Throughout his life, Al was passionate about philanthropy and was dedicated to prolonging and improving the quality of human lives through innovation in the fields of healthcare and the use of medical devices. It was important to Al that his success and assets continue to better human lives even after his own passing.   Alfred E. Mann Charities, Inc. (formerly known as Alfred E. Mann Family Foundation) has similarly placed its primary focus on healthcare and medical innovation, as our organization believes this is where we can have the greatest impact on humanity and human health throughout the world. Alfred E. Mann Charities, Inc. is also dedicated to promoting arts, culture, education, and community development across Los Angeles and throughout the world in order to best serve people and this planet.   Learn more at aemanncharities.org.   About The Diabetes Link The Diabetes Link is the only national nonprofit organization dedicated to empowering young adults living with diabetes. Founded by and for young adults, The Link serves this community through peer support, leadership opportunities, and practical, evidence-based resources designed for real life. Its network of campus and community chapters, active online community, and robust Resource Hub help young adults navigate the transitions of early adulthood while managing diabetes. The organization envisions a future where every young adult living with diabetes has

The quarterback Transfer Portal market will see a lot of tampering, especially with multiple G6 quarterbacks playing big-time football. I define the top G6 quarterbacks and why they will be coveted. There are P4 names to discuss too.Will a big-time talent like Kansas State's Avery Johnson hit the Portal? How about South Carolina's LaNorris Sellers? I explain how complicated those situations could be.As always, the latest recruiting news.@fbscout_florida On X @LO_ThePortal TikTok @lockedontheportalSupport us by supporting our sponsors!DoorDashWith DoorDash Streaks, you save every Saturday you order — stack it up all season and you could save up to $250. Order this Saturday. Keep the streak alive. Fuel your gameday — only with DoorDash. Terms apply. Promo period through 11/18.SupplyHouseJoin the free TradeMaster program today and score serious perks like priority shipping, lower prices, and a dedicated support line. Visit SupplyHouse.com to sign up for free and use promo code SHCOLLEGE5 for 5% off your first order.GametimeToday's episode is brought to you by Gametime. Download the Gametime app, create an account, and use code LOCKEDONCOLLEGE for $20 off your first purchase. Terms and conditions apply.FanDuelToday's episode is brought to you by FanDuel. Football season is around the corner, visit the FanDuel App today and start planning your futures bets now.FANDUEL DISCLAIMER: 21+ in select states. First online real money wager only. Bonus issued as nonwithdrawable free bets that expire in 14 days. Restrictions apply. See terms at sportsbook.fanduel.com. Gambling Problem? Call 1-800-GAMBLER or visit FanDuel.com/RG (CO, IA, MD, MI, NJ, PA, IL, VA, WV), 1-800-NEXT-STEP or text NEXTSTEP to 53342 (AZ), 1-888-789-7777 or visit ccpg.org/chat (CT), 1-800-9-WITH-IT (IN), 1-800-522-4700 (WY, KS) or visit ksgamblinghelp.com (KS), 1-877-770-STOP (LA), 1-877-8-HOPENY or text HOPENY (467369) (NY), TN REDLINE 1-800-889-9789 (TN) Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Boise State QB Max Cutforth, who will make his first college start Saturday at San Diego State, met with the media after Tuesday's practice and talked about his growth during the bye week, where he's better than the injured Maddux Madsen and his plan to keep the starting job once Madsen returns from a lower-leg injury, Bob takes a look at Boise State's backup QB history in Bronco Focus (Hedrick, Rypien, Henderson, Sears, Tiller), former Broncos Tyson Degenhart (Raptors) and O'Mar Stanley (Pistons) made their G-League debuts, how you handling the ESPN-YouTube dispute, new CFP rankings/bracket (who's representing the G6?)See omnystudio.com/listener for privacy information.

Boise State QB Max Cutforth, who will make his first college start Saturday at San Diego State, met with the media after Tuesday's practice and talked about his growth during the bye week, where he's better than the injured Maddux Madsen and his plan to keep the starting job once Madsen returns from a lower-leg injury, Bob takes a look at Boise State's backup QB history in Bronco Focus (Hedrick, Rypien, Henderson, Sears, Tiller), former Broncos Tyson Degenhart (Raptors) and O'Mar Stanley (Pistons) made their G-League debuts, how you handling the ESPN-YouTube dispute, new CFP rankings/bracket (who's representing the G6?)See omnystudio.com/listener for privacy information.

Boise State QB Max Cutforth, who will make his first college start Saturday at San Diego State, met with the media after Tuesday's practice and talked about his growth during the bye week, where he's better than the injured Maddux Madsen and his plan to keep the starting job once Madsen returns from a lower-leg injury, Bob takes a look at Boise State's backup QB history in Bronco Focus (Hedrick, Rypien, Henderson, Sears, Tiller), former Broncos Tyson Degenhart (Raptors) and O'Mar Stanley (Pistons) made their G-League debuts, how you handling the ESPN-YouTube dispute, new CFP rankings/bracket (who's representing the G6?)See omnystudio.com/listener for privacy information.

Oppa Gangnam Style! On this episode of Baconsale, we're putting one-hit wonders that were Classic around 7 Years ago on a bracket. We'll have many Little Talks to decide which tracks are Bulletproof and which ones don't deserve a Replay. We may leave some millennials Brokenhearted as we Say Something negative about a song they love, but Don't You Worry Child, we don't mean to make Waves. You just need to Let It Go. Joel, Kent, and Zack are going to Sail through this first round of 64 songs. However, we won't finish the tournament Tonight Tonight. It is Written in the Stars that we'll pick a winner next time (Like a G6).   So say Geronimo, enjoy the Sweater Weather, and press play!   Visit Baconsale.com to find our official Spotify playlist and download this bracket.

College Football Week 11 was a story of survival, domination, and conference shakeups. In this college football podcast episode, we unpack a crazy week with Indiana and Oregon on the brink of losing in tough road spots, with Texas Tech dominating another Big 12 opponent, and with both Virginia and Louisville losing at home and throwing the ACC into further chaos. Plus, we take a look at impressive showings by Georgia and Texas A&M, Alabama's lumpy win over LSU, Vandy's overtime shootout with Auburn, and the sudden rise of Zombie Kentucky. And finally, we play your voice messages, hand out our Dude Alerts for the top Week 11 performers, and muse over the latest G6 playoff scenarios featuring North Texas, USF and Tulane. Timecodes:0:00 - Intro6:17 - Indiana survives Penn State13:14 - Oregon escapes Iowa20:58 - Texas Tech dominates BYU26:46 - Wake Forest upsets Virginia29:56 - Cal beats Louisville in OT32:18 - Other ACC Games34:40 - Georgia hammers Mississippi State36:14 - Texas A&M destroys Missouri41:17 - Alabama beats LSU44:38 - Vandy wins in OT51:44 - Other Big 12 Games54:19 - Kentucky clobbers Florida55:49 - Other Big Ten Games1:04:49 - G6 Playoff Chase1:10:26 - Week 11 Reverbs1:18:13 - Dude AlertsSupport the show!: https://www.patreon.com/solidverbalSee omnystudio.com/listener for privacy information.

Eat your broccoli and get ready for a loaded Week 11 slate, featuring top five teams on the road, sandwich games, interim coaches and plenty of potential chaos. On today's college football podcast episode, we deep dive the games we didn't discuss on Tuesday and break down a defanged Indiana vs Penn State matchup, a classic letdown-lookahead spot for Georgia, a road test for Texas A&M, and potential for the "After Brian Factor" to have an impact on LSU vs Alabama. Plus, a muted but fascinating Florida State vs Clemson showdown, a monster G6 meet-up between Tulane and Memphis, and a true test of the Ty Jinx in Washington vs Wisconsin. We also take a look at the first CFP Rankings and the projected playoff bracket, give you a handful of under-the-radar games to be aware of, keep you up to date on the upcoming Patriot League action, and offer some guidance for getting out of the house on a college football Saturday. Play in our new Fantasy Coaching Carousel game right here: https://www.solidverbal.com/carousel Timestamps:0:00 - Intro & Saturday Nicknaming9:42 - First CFP Rankings & Bracket Reveal18:19 - Picks of the Week20:00 - Indiana vs Penn State Predictions27:34 - Georgia vs Mississippi State Predictions34:10 - Texas A&M vs Missouri Predictions40:41 - LSU vs Alabama Predictions47:55 - Washington vs Wisconsin Predictions51:13 - Florida State vs Clemson Predictions57:00 - Wake Forest vs Virginia Predictions59:20 - Navy vs Notre Dame Predictions1:01:12 - Tulane vs Memphis Predictions1:04:35 - Under the Radar Games1:16:00 - Pat League Lightning Round1:20:53 - Week 11 Window of OpportunitySupport the show!: https://www.patreon.com/solidverbalSee omnystudio.com/listener for privacy information.

Getting to know two Boise State QBs - redshirt freshman Max Cutforth (new starter for San Diego State on Nov. 15?) and incoming recruit Jackson Taylor (Thousand Oaks, California), we talk to Cutforth's high school coach, David Robinson of Skyview High in Nampa, and Taylor joins the show to describe what attracted him to Boise State and when he plans to be in Boise, are the CFP and G6 programs headed for a divorce, Bob previews the last month of the Mountain West football regular season in Bronco Focus, Timberline High coach Ian Smart (former Boise State DL, 2004-07) talks about being a No. 1 seed in the 6A quarterfinals that start Friday night in Boise See omnystudio.com/listener for privacy information.

Getting to know two Boise State QBs - redshirt freshman Max Cutforth (new starter for San Diego State on Nov. 15?) and incoming recruit Jackson Taylor (Thousand Oaks, California), we talk to Cutforth's high school coach, David Robinson of Skyview High in Nampa, and Taylor joins the show to describe what attracted him to Boise State and when he plans to be in Boise, are the CFP and G6 programs headed for a divorce, Bob previews the last month of the Mountain West football regular season in Bronco Focus, Timberline High coach Ian Smart (former Boise State DL, 2004-07) talks about being a No. 1 seed in the 6A quarterfinals that start Friday night in Boise See omnystudio.com/listener for privacy information.

Getting to know two Boise State QBs - redshirt freshman Max Cutforth (new starter for San Diego State on Nov. 15?) and incoming recruit Jackson Taylor (Thousand Oaks, California), we talk to Cutforth's high school coach, David Robinson of Skyview High in Nampa, and Taylor joins the show to describe what attracted him to Boise State and when he plans to be in Boise, are the CFP and G6 programs headed for a divorce, Bob previews the last month of the Mountain West football regular season in Bronco Focus, Timberline High coach Ian Smart (former Boise State DL, 2004-07) talks about being a No. 1 seed in the 6A quarterfinals that start Friday night in Boise See omnystudio.com/listener for privacy information.

Mike Vallerie (@FF_DirtyMike) and Cory Pereira (@FF_Guitarist) are bringing up some under-the-radar and rising names we haven't talked about enough. They'll discuss their favorite G6 guys who could climb into the P4, as well as names like Darian Mensah, Emmett Johnson, Cooper Barkate and more!

It is hard to survive in today's world of college football if you don't have enough money to pay players. Former Mac Conference Commissioner Rick Chryst explains why G6 schools are now like a feeder system to the P4 schools.

Indiana football's Transfer Portal wins are incredible. Curt Cignetti & the Hoosiers found more gems from the G6 and FCS level who become big-time players than any other major college football program. It's time to break it down.The Hoosiers are on a collision course with Ohio State. Can the Hoosiers knock off the defending national champions?@fbscout_florida On X @LO_ThePortal TikTok @lockedontheportalSupport us by supporting our sponsors!PelotonLet yourself run, lift, flex, and push forward. Explore the new Peloton Cross Training Tread+ today at https://www.onepeloton.com.DoorDashWith DoorDash Streaks, you save every Saturday you order — stack it up all season and you could save up to $250. Order this Saturday. Keep the streak alive. Fuel your gameday — only with DoorDash. Terms apply. Promo period through 11/18.MazdaIt's the small details that make the big plays. And just like there's more to every player, there's more to a Mazda vehicle. Mazda. Move and Be Moved. GametimeToday's episode is brought to you by Gametime. Download the Gametime app, create an account, and use code LOCKEDONCOLLEGE for $20 off your first purchase. Terms and conditions apply.FanDuelToday's episode is brought to you by FanDuel. Football season is around the corner, visit the FanDuel App today and start planning your futures bets now.FANDUEL DISCLAIMER: 21+ in select states. First online real money wager only. Bonus issued as nonwithdrawable free bets that expires in 14 days. Restrictions apply. See terms at sportsbook.fanduel.com. Gambling Problem? Call 1-800-GAMBLER or visit FanDuel.com/RG (CO, IA, MD, MI, NJ, PA, IL, VA, WV), 1-800-NEXT-STEP or text NEXTSTEP to 53342 (AZ), 1-888-789-7777 or visit ccpg.org/chat (CT), 1-800-9-WITH-IT (IN), 1-800-522-4700 (WY, KS) or visit ksgamblinghelp.com (KS), 1-877-770-STOP (LA), 1-877-8-HOPENY or text HOPENY (467369) (NY), TN REDLINE 1-800-889-9789 (TN)

It was a Statement Saturday around college football as some conference favorites and title contenders made strong impressions, while others failed in the moment. We discuss Texas A&M's path to a national title, Brian Kelly's failure at LSU, huge wins in the Big XII, and zoom in on the G6 race for the playoff!Play $5 and get $100 instantly (limited time only!) in fantasy bonus funds when you use code THREETECHPOD with our presenting sponsor, Underdog Fantasy! ⁠⁠⁠⁠⁠⁠⁠https://underdogfantasy.com/⁠⁠⁠⁠⁠⁠⁠Join the Jimmy's and Joe's for CFB content for all 136 teams!FOLLOW: @ThreeTechPod on Instagram and Twitter!HOMEFIELD DISCOUNT: THREETECHPOD for 15% off!Join our Substack: https://threetechpod.substack.com/

The romanticized image of the endlessly wealthy sugar daddy showering his companion with private jets and designer bags is fading in the face of harsh economic realities. A broad economic squeeze is impacting benefactors, who are increasingly mid-career professionals rather than just the ultra-rich, and they are finding it difficult to maintain the "G6 lifestyle." As one article highlights, these men are now skipping their own meals to cover a sugar baby's nail appointment and lamenting that they can only afford "Delta Economy Class." This financial strain has given rise to "Splenda daddies" and "salt daddies," men who can no longer be as generous as they once were, leading to disappointment and conflict within these transactional relationships.Sugar babies are feeling the pinch as well, with one complaining her lavish birthday expectations of a trip to the Philippines were dashed when she received a pair of headphones. This new dynamic, where "prices are getting higher, and sex is getting cheaper," has intensified the "hustle" for sugar babies. Finding a viable benefactor has become a tactical operation, with guides suggesting potential babies strategically position themselves in specific high-end locales. These include exclusive hotel bars, the service centers of luxury car dealerships, private airport terminals, and specific seating levels at major sporting events, all in a calculated effort to "meet their next benefactor out in the wild."However, this increased financial pressure and the inherent nature of the arrangements can lead to far more extreme and manipulative behaviors. When these "mutually beneficial" relationships break down, some sugar babies have resorted to criminal extortion and fraud. A legal analysis of sugar dating in Singapore highlights several court cases where these tactics were employed. In one instance, a 23-year-old woman was jailed for cheating a man out of over S$8,000 after pretending to be underage. In another case, a woman filed a false rape report against her sugar daddy following a dispute over payment. Other common manipulative tactics include catfishing, lying about one's age, and, most notably, extortion by threatening to expose intimate materials or the nature of the relationship itself.Become a supporter of this podcast: https://www.spreaker.com/podcast/depraved-and-debaucherous--5267208/support.Contact KOP for professional podcast production, imaging, and web design services at http://www.kingofpodcasts.comSupport KOP by subscribing to his YouTube channel and search for King Of PodcastsFollow KOP on X and TikTok @kingofpodcasts (F Meta!)Listen to KOP's other programs, Podcasters Row… and the Wrestling is Real Wrestling Podcast and The Broadcasters Podcast.Buy KOP a Coffee https://buymeacoffee.com/kingofpodcastsDrop KOP a PayPal https://www.paypal.com/donate?hosted_button_id=3TAB983ZQPNVLDrop KOP a Venmo https://account.venmo.com/u/kingofpodcastsDrop KOP a CashApp https://cash.app/$kingofallpodcasts

Tonight was supposed to be a fun loving good ole fashioned laid back chill night on Twitch. BUT, as the conversation geared towards G7 and player expectations, we started having a great conversation, and it just HAD to be turned into a show. Shoutout to MOOPSIE for kicking us off tonight on what turned out to be an AMAZING conversation about G7's first week.  here are your timestamps:  00:00:00 – Opening chatter and unexpected “interloper” joins 00:03:00 – Moopsie returns, teasing a new “Downfall” parody video about G7 00:06:00 – Breaking down launch bugs, errors, and frustrations from players 00:08:45 – Discussion of paywalls and time-gating in the G7 expansion 00:12:00 – DJz and Griffin counter with positive experiences from their alliances 00:15:30 – Arguments over Scopely's pacing – slow by design or poor delivery? 00:18:00 – Moopsie details his “broken miner” issue in the Veil and Scopely's silence 00:21:30 – Server-sync bug explanations and talk of compensation for affected players 00:25:00 – DJz acknowledges communication failures but defends overall design intent 00:27:45 – Day-eight perspective – reminding players G7 is still new content 00:31:00 – Conversation shifts philosophical – how much patience should players have? 00:33:30 – “Camping chair” analogy – DJz explains his philosophy on value and spending 00:36:30 – Chat debate on refunds, spending habits, and game enjoyment 00:39:30 – Griffin compares Scopely criticism to consumer protest culture 00:42:00 – Community frustration vs. personal enjoyment – finding the balance 00:45:00 – Transition to listener participation and open-mic discussions 00:47:00 – K9 joins the show (Ops 72) to voice G7 concerns from a whale's view 00:49:00 – Forced collaboration complaint – Veil and Surge systems under fire 00:53:00 – DJz questions how this differs from earlier generations' content 00:56:00 – K9 explains the problem of investment scale and reset fatigue 00:59:00 – High-cost progression to 73+ – too steep for meaningful advancement 01:02:30 – Debate on “slow by design” – whether G6 feedback caused the shift 01:06:00 – Player isolation vs. forced teamwork – balancing design philosophies 01:10:00 – Hazards vs. Veil – comparing past solo mechanics to new alliance ones 01:14:00 – Arguments over accessibility and alternate progression paths 01:18:00 – Acknowledging Scopely's challenge – serving five generations of players 01:22:00 – Finding middle ground – Veil as both opportunity and limitation 01:26:00 – DJz reinforces Talking Trek's open-platform approach to criticism 01:30:00 – Audience Q&A – who actually enjoys G7 so far? 01:33:00 – Positive reports from chat – players share early success stories 01:37:00 – Discussion about whales, catch-up mechanics, and compressed content 01:41:00 – Frustration over required alliance activity and dependency 01:45:00 – Hazards, surges, and solo play revisited – the ongoing debate 01:49:00 – DJz mediates closing thoughts – fun, freedom, and fair design 01:54:00 – Wrap-up, post-show Discord invite, and lighthearted closing banter

Damn it feels good to be a gansta, AMIRITE? OR AMIRITE? Rent Money collabs with Floppy Sloppy Head as RunItBackJones, Ole Chisum and Texas Pete spit something special for your ear drums. Bless up. We should consider ourselves lucky we get to listen to these 3 floppy sloppaz every week! Now it's time for the AI generated summary which is WAY less fun but probably WAY more impactful for viewership or whatever:In this episode of Rent Money, the hosts dive into a weekend full of college football action, discussing the major losses of teams like Texas and Penn State, the return of quarterback Nico Iamalavea, and the upcoming Red River Rivalry between Texas and Oklahoma. They also preview a thrilling Friday night matchup between North Texas and USF, highlighting the excitement surrounding G6 football. The conversation is filled with humor, insights, and a deep love for the game. In this episode, the hosts delve into various topics surrounding college football, including coaching changes, game predictions, and the dynamics of betting. They analyze the upcoming game between Indiana and Oregon, share personal stories related to fantasy football, and discuss the joys of having free weekends. The conversation is filled with humor, historical references, and insights into the world of sports and life.

V 169. epizóde videopodcastu venujeme pozornosť dvom automobilom z našich redakčných testov: čínskemu SUV Xpeng G6 Performance a americkému pick-upu Ford Ranger Wildtrak X. Xpeng G6 a Ford Ranger nie sú konkurenti, pretože sú celkom odlišnými typmi automobilov. Zatiaľ čo Xpeng G6 je luxusné elektrické SUV s dôrazom na komfort v interiéri a technologický náskok, Ford Ranger je úžitkové vozidlo s plnou korbou pridaných hodnôt. Cena oboch testovaných vozidiel je však veľmi podobná, mierne presahujúca hranicu 55-tisíc eur.Test Xpeng G6 PerformanceČínske automobilky valcujú a zrejme skutočne prevalcujú európsku konkurenciu. V uplynulom období na Slovensko formálne vstúpilo hneď niekoľko nových ázijských značiek, spomeňme BYD, HongQi, Xpeng, Omoda, Jaecoo či najnovšie Leapmotor. A pripravujeme sa na príchod BAIC.Xpeng patrí medzi tie zo značiek, ktoré otvorene konkurujú Tesle a modelom EQ od značky Mercedes-Benz. Zaujať zákazníka mieni agresívnou cenovou politikou, no najmä oslovením všetkých zmyslov - vrátane chuti, ak myslíme na metaforickú chuť na inovatívny pohon. Testovacia jazda totiž zaujme natoľko, že človek sa začne spytovať, prečo nie sú európske elektromobily na takejto vysokej úrovni. Jazdné vlastnosti, technologická vyspelosť, vysoká bezpečnosť a úroveň pohodlia vpredu aj vzadu, to všetko G6 ponúka už v základe. My sme mali možnosť vyskúšať verziu Performance, ktorá vyniká obratnosťou, dynamikou a pružnosťou v zdanlivo akejkoľvek rýchlosti. Xpeng G6 Performance testoval Erik Stríž z Autobazar.EU.Text Ford Ranger WildTrak XFord Ranger je najpredávanejší a najobľúbenejší pick-up, ale aj dobrý základ pre imidžové konfigurácie. Verzia WildTrak X obsahuje početné vylepšenia pre náročných, ktoré zlepšujú jazdný komfort, ale aj užitočné doplnky pre jednoduchší prevoz dlhého nákladu.Ako tento naftový pick-up s dvojitým turbom jazdí, v čom sa líši od ostatných verzií a prečo je o 15-tisíc eur drahší ako iná podobná verzia, objasňuje novinár Jozef Murárik.

We thought Week 6 would be quiet. We were wrong. Dead wrong. Three top 15 teams fell to unranked opponents in what might be the most chaotic Saturday of the season. We dive deep into Penn State's shocking 42-37 loss to UCLA—a team that fired its coach just days earlier. The loss raises serious questions about James Franklin's future despite his $50+ million buyout. Can this relationship be salvaged? We also break down Florida's inspired 29-21 upset of Texas in The Swamp, where the Gators' defense sacked Arch Manning six times and exposed flaws in the Longhorns' offensive line. Plus, Miami continues to look like a legitimate contender with a dominant road win over Florida State, powered by freshman sensation Malachi Toney and an elite defensive front. Beyond the headline upsets, we analyze Alabama's methodical win over Vanderbilt, Cincinnati's offensive explosion against Iowa State, Bryce Underwood's career day against Wisconsin, and what all this chaos means for the playoff picture. To close things out, Ty reveals his updated top 12 rankings, we answer live Verballer questions about Ohio State inevitability, the best G6 teams, and the champions of NIL, and finally, hand out Dude Alerts to standouts like Bear Bachmeier, Dallas Wilson, and Ty Simpson. Timestamps: 0:00 - Intro3:04 - UCLA upsets Penn State15:33 - Miami beats Florida State22:34 - Florida upsets Texas30:52 - Alabama gets revenge on Vandy36:13 - Cincy dumps Iowa State39:03 - Other Big 12 Thoughts41:33 - Other Big Ten Thoughts48:24 - Other ACC Thoughts53:12 - Other SEC Thoughts + Notre Dame55:16 - Ty's New Top 1258:06 - Week 6 Reverbs1:01:43 - Questions from YouTube1:12:58 - Dude AlertsSupport the show!: https://www.patreon.com/solidverbalSee omnystudio.com/listener for privacy information.

It's Arcfall Eve Eve! DJs, Griffin, and the crew bring the laughs, leaks, and lore as they break down the USS Dauntless, Bek's reveal video, and what's ahead in Update 83. From playtest footage to automation mechanics and community Q&A, this episode is the perfect mix of humor and teaching as Talking Trek gears up for Arcfall 2025. Timestamps 0:00 – Intro, greetings, and server roll call 3:40 – “Arcfall Eve Eve” hype and DJz' weekend preview 6:10 – Griffin joins / chat chaos and banter 8:50 – DJz defeats a Vengeance (and won't stop talking about it) 12:00 – Community teasing and “captain's chair” jokes 15:30 – Bek's reveal video announcement 17:15 – What to expect from Update 83 20:00 – “Seek and Destroy” teaser and first impressions 22:40 – Dauntless early blueprints confirmed 25:00 – Server-side automation explained 28:00 – Discussion: why this is not another Kirshara 31:00 – Crew builds and automation Q&A 34:10 – Apex Barrier explained 37:00 – Loot buffs and tier-up reward mechanics 39:20 – Daily activation limits and strongbox charges 42:00 – Debate: is automation good for gameplay? 46:00 – Tier 1 stats and early performance 49:10 – Damage scaling and PvE optimization 52:20 – Crew testing results from Bek's playtest 56:00 – Viewer Q&A: sourcing, costs, and progression 1:00:00 – Griffin's theory on Artfall tie-ins 1:05:00 – Hidden power creep and Dauntless overlap 1:10:20 – Historical comparison: G4, G5, and now G6 automation 1:15:00 – DJz praises Bek's communication and data clarity 1:20:30 – JulesVern joins with testing spreadsheets 1:25:00 – Community call-ins: first reactions from high-level ops 1:30:10 – Server performance talk and lag fixes 1:34:00 – Deep dive into damage math 1:38:40 – Griffin's “math face” meme moment 1:42:00 – DJz polls chat on automation fairness 1:47:00 – PvE vs PvP implications 1:51:00 – Comparison to G6 resource ships 1:55:00 – Away Teams / Dauntless synergy 2:00:00 – Arcfall event structure preview 2:05:20 – Free-to-play timeline for ship unlock 2:10:00 – Community sentiment: excitement vs skepticism 2:15:30 – Griffin's “just let me grind” rant 2:20:00 – DJz final impressions on ship balance 2:25:10 – Open Q&A from chat 2:30:00 – Misc topics: G7 rumors, bug fixes, random tangents 2:40:00 – Wrapping up Arcfall talk / viewer shout-outs 2:50:00 – Crew farewells and closing laughs 2:59:00 – End credits and outro

Caio Villela comenta o triunfo sobre o Fortaleza na arena Castelão com gols de Tapia e Luciano. O Tricolor se recupera após quatro derrotas seguidas mesmo jogando boa parte com um a menos após a expulsão de Rigoni. Time está na sétima posição a dois pontos do Bahia que fecha o G6. Próximo compromisso será o clássico contra o Palmeiras no Morumbis. Tayna Fiori traz uma entrevista exclusiva com Bia Menezes, atleta do futebol feminino. Clica aí!

This week on Talking Trek Live, DJs, Griffin, and Jules Verne deliver laughs, updates, and strategy! From Griffin's infamous $7,000 “Vengeance” toilet to Scopely's latest event reward changes, we cover it all before diving into a full 2025 G6 entry guide. With guest Putz fresh into Ops 64, the crew breaks down warp requirements, ship setups, event scaling, and everything you need to know before making the leap into G6.   0:00 – Opening greetings, server roll call, and audience check-in 3:40 – Griffin's $7,000 “Vengeance” toilet story 8:00 – Ghost Energy sponsorship segment & flavor news 10:40 – Special guest Jules Verne introduced (“mad scientist”) 12:10 – Armada event reward changes announced 15:30 – Crucible of War returning & reworked prize pools 20:00 – Why DJs chose Planetary Charts as a reward currency 25:00 – Community pushback, DJz explains his reasoning 32:00 – New Transporter Pattern officers added (Borg Queen, Hugh, Weyoun, Dukat) 34:00 – Transition into G6 content guide 36:00 – Putz joins the stage (just hit Ops 64 / G6) 38:00 – Storytime: hitting a deer on the way to the show 40:20 – Why Putz decided to jump into G6 now 41:30 – Early G6 warp requirements & ship setups 43:20 – Auction bracket changes and event scaling in G6 47:00 – Strategic timing of your Ops 61 push 50:00 – Away Team Assignments, caps, and planetary charts revisited 55:40 – Revenant chest timing & mirror universe speed-up farming 1:27:00 – G6 ship breakdown: Vindicator, Revenant, Relativity 1:39:45 – Hazard resistance mechanics & new solo G6 Armadas 1:52:10 – Free-to-play progression of the Junker & relativity use cases 2:05:20 – Reputation scaling past Ops 60 & closing notes 2:07:00 – Final wrap-up, plugs, and goodbyes

Depois de duas vitórias seguidas, Galo fica no empate sem gols contra o Juventude. Qual a realidade do time no campeonato? Briga no G6 ou por vaga na Sul-Americana ou será luta contra o Z4? Por que o ataque não está funcionando? Hulk fez muita falta? Quais jogadores já podem ser considerados titulares de Sampaoli? Contra o Fluminense, já vale testar o time que jogará a semifinal da Sul-americana contra o Del Valle? Com André Ribas, Henrique Fernandes, Carol Leandro e Rogério Corrêa. A edição é de Leticia Araújo.

Don't miss the latest episode of College Football Now, as host Thomas Christopher and multiple members of The League Winners discuss the latest in CFB news, players, and events for the 2025 season. While you're listening to the show, please make sure to like the video, leave a comment, and subscribe to the channel!In the latest episode of College Football Now, the topic of conversation is The League Winners rankings, P4 recaps and previews, and highlighting some of the key moments in college football.Starting the show with Thomas Christopher and Brandon Haye, the duo talks Florida football, and other massive college football matchups. Then, Thomas is joined by Daily Cal's Joaquin Ruiz, to discuss the Week 6 matchup between the California Golden Bears and the Duke Blue Devils.Finally in the P4 segment comes to an end with Shane Barrett, discussing the Auburn Tigers.Joining Thomas to talk about Syracuse's Week 6 matchup against the SMU Mustangs is Daniel Tortora, formerly of ESPN and FOX Sports, who is host of The Wake Up Call with Dan Tortora.Later in the show, The League Winners stick go to the G6, as Mackenzie Neglia discusses the continued emergence of the USF Bulls. And, their upcoming conference play matchup.Then, Thomas is joined by New Era Prep writer Robbie Lastella to talk FAU's matchup against Rice in a battle of the Owls. East Coast Correspondent Brandyn Pokrass also joins the show with a video blurb discussing FAU, FIU, and USF.The League Winners are a company dedicated to covering the college football and the NFL. Created by Thomas Christopher, TLW was created to give football fans news, highlights, interviews, film review and much more surrounding the game of football.#USF #CollegeFootball #SouthFlorida #FAU #FSU #Auburn #Syracuse #CollegeFootballPodcast #CFB25 #CollegeFootball2025 #SyracuseOrange #FAUOwls #FSUSeminoles #AuburnTigers #USFBulls #LeagueWinners #CalBears #CalFootball

Aconteceu! Depois de oito vitórias seguidas sobre o rival, o Botafogo foi derrotado pelo Fluminense. Quais as consequências da quebra desse jejum que durava três anos? Quem é o maior culpado pela campanha irregular na temporada: Davide Ancelotti, John Textor ou o elenco? O torcedor deve assinar G6 ou pode sonhar ainda com o G4 do Brasileirão? Claudio Portella, Maria Clara Modesto, Pedro Dep e Sergio Santana vão responder essas e outras questões. A coordenação é do Paulo Vitor Ferreira, o PV. Dá o PLAY!

Appalachian State made the trip out west for a matchup against another premium G6 brand. But it wasn't great. We talk about the game and try not to turn it over. 

Posledné týždne v období okolo autosalónu IAA 2025 v Mníchove

Tonight we deep dive into the abilities to tier up the new Prototype Forbidden Techs, and then focus on MORE rewarding content, the Reliant and the Wrath of Khan loop as F2P have officially unlocked their new ship, so how do you engage now that we've tested the waters and shown the best ways to engage.    0:00 – Cold open chaos & endless alerts 2:20 – Official show start, server sound-off, community shoutouts 4:00 – Tonight's agenda: prototype forbidden tech, Bek's return, heroic events 5:30 – Meeting recap with Bek: energy, initiatives, and drama in whale Discord 8:10 – First reactions to prototype forbidden tech – lackluster or misunderstood? 10:30 – Scopely's intent: new combinations vs. invalidation of old tech 13:40 – The community dilemma: “We don't want invalidation… but why buy duplicates?” 16:50 – Time-to-max math: years vs. immediate value problem 18:45 – Recon Locus building comparison – when grind feels reasonable 21:00 – Automotive analogy: building customer trust & value through transparency 27:30 – Customer service story & lessons applied to STFC monetization 30:10 – Why players aren't spending on prototype tech this month 33:00 – Heroic events: grind vs. spend, ops-level challenges 36:40 – Hostile math: required kills, building level dependence 40:00 – G5 vs. G6 analysis: progression gaps and grinding realities 45:00 – Deep dive into Counterplay Device (Explorer prototype tech) 47:30 – Mid-tier stats vs. max stats: is the payoff worth the time? 50:00 – Free-to-play strategy: rare pulls, saving for future tech 53:00 – Spreadsheet walk-through: banner income vs. refinery pulls 54:50 – Community sentiment: disengagement from spending 57:00 – Open mic: guest perspectives, Eco's heroic event math misfires 1:10:00 – Value, perception, and the predictability problem 1:25:00 – More on Bek's role & player feedback loops 1:40:00 – PvP applications of prototype tech 2:00:00 – Panel debate: is Scopely out of touch with player priorities? 2:20:00 – Lessons from other arcs & monetization models 2:40:00 – Final roundtable: what needs to change 2:55:00 – Closing thoughts & community thanks

Welcome to the 8th Episode of I Can Dance to That with pspsps, where we blur the lines between tech house, bass house, and techno. Today we go full on warehouse vibes, so be sure to turn up the subs for that bass in your face. As always, I've got some brand new and unreleased bangers from myself and my friends, including an epic edit of Like a G6 by Phat Suppli, so keep your ears peeled for that one. ⚡️Like the Show? Click the [Repost] ↻ button so more people can hear it!

Talking Trek Live – September 11, 2025 UltimatDJz and the crew break down the September arc's targeted progression, the Hyperthermic Stabilizer/decay loop, refinery changes at 51+, and G6 hostile realities—plus a very real “Dad, don't be mad” Chevy Equinox saga. Packed with teaching from Jules Verne, live chat energy, and practical grind strategies. Timestamps 00:00 – Opening & greetings 00:02 – Server sound-off and early hype (APAC shout, bonus streams) 05:16 – Bonus stream counter, sound alerts, Gamer Optics glasses chat 11:31 – “Dad, don't be mad” call: the Equinox knocking/engine story 17:35 – DJz sets a two-hour hard-out; hands show to Jules Verne 18:38 – Jules intro; arc theme: aggregation & targeted ops experience 37:17 – Free-to-play pulse check: early building levels, chat poll 38:22 – Gift chest “470”, early progression, exponential costs 39:20 – Hyperthermic Stabilizer explained; 25% G4 decay & mitigation 1:08:57 – Forbidden Tech tiering at Ops 51; epics to T6 L30 pre-61 1:10:05 – Why G5 design here is unusually generous + RNG avoidance 1:11:23 – At 51, refinery adds banner → double Locus mats/research/legacy FT 1:21:53 – Building 61 preview; natural 61–66 G6 hostile band & stats spike 1:36:00 – Bundles, “unobtainium chest” vibes, heroic = spender reward 1:44:05 – Stream crash → Microsoft forced update; show resumes/splits 1:46:54 – Final teaching topic cue (crits/epic hostiles), moving to wrap 1:52:31 – Vengeance updates: earlier BDO slots; PvP node via engagement 2:06:30 – Recon Locus economy: banners, skip research early, bank for Stasis Globe 2:10:06 – Planet Ingram chatter; “getting ready to wrap” 2:12:29 – Shout-outs & plug: STFC Briefings (Nigel + Jules) 2:14:19 – Cruise sweepstakes redraw announcement & final sign-off (“Meow for now”)

Don't miss the latest episode of College Football Now, as host Thomas Christopher and multiple members of The League Winners discuss the latest in CFB news, players, and events for the 2025 season. While you're listening to the show, please make sure to like the video, leave a comment, and subscribe to the channel!In the fourth episode of College Football Now, the topic of conversation in our opening segment is the Shula Bowl! Thomas Christopher is joined by Brandyn Pokrass (The League Winners) and Robbie Lastella (New Era Prep) to discuss the matchup between Florida Atlantic and Florida International. The FAU vs. FIU matchup comes in Week 3. The two will also recap their two team's respective Week 2 matchups.Later in the show, The League Winners stick with the G6, as Mackenzie Neglia and Brandyn Pokrass discuss the emergence of USF, their back-to-back upsets, and Week 3 versus Miami.Before the brief intermission, Thomas discusses the Delaware Blue Hens, and goes over The League Winners' Power Rankings entering Week 3. The League Winners recently introduced their own Top-25 Power Rankings for the 2025 college football season.The second half of these 2025 Week 3 season previews focuses on the Power Conferences and their opponents. Beginning the P4 segment, Thomas is joined by Daily Cal's Joaquin Ruiz, to discuss the Week 3 matchup between the California Golden Bears and the Minnesota Golden Gophers.Joining Thomas to talk about Syracuse's Week 3 matchup against Colgate is Daniel Tortora, formerly of ESPN and FOX Sports, who is host of The Wake Up Call with Dan Tortora.The League Winners are a company dedicated to covering the college football and the NFL. Created by Thomas Christopher, TLW was created to give football fans news, highlights, interviews, film review and much more surrounding the game of football.

Tuesday's 7am hour of Mac & Cube started off with the guys saying how small, early in the season, the talent gap is between G6 players and the P4 isn't as wide as people would think; then, Pat Dooley, who covers the Florida Gators, tells us what's going on behind the scenes involving Billy Napier and the Gators, how heathy Florida is, and why they have to figure out how to play Florida Gator football; later, Cole & Greg wonder what Florida can do to right the ship; and finally, we look back at Week 1 of the NFL and the top performances. "McElroy & Cubelic In The Morning" airs 7am-10am weekdays on WJOX-94.5!See omnystudio.com/listener for privacy information.

Don't miss the latest episode of College Football Now, as host Thomas Christopher and multiple members of The League Winners discuss the latest in CFB news, players, and events for the 2025 season. In the third episode of College Football Now, the topic of conversation is Power Rankings! The League Winners recently introduced their own Top-25 Power Rankings entering Week 2 of the 2025 college football season. Host Thomas Christopher and Brandyn Pokrass discuss the list, before switching the conversation to a recap of the Week 1 matchups from last week.After that recap, The League Winners move on to discuss Week 2 of the 2025 CFB season. The first portion of these game previews will be discussing the G6 and FBS-level, where multiple correspondents of The League Winners were be present, or presenting video/written blurbs about their team's matchup.The second half of these 2025 Week 2 season previews focuses on the Power Conferences and their opponents. Alongside Thomas will be numerous members of The League Winners' staff. This includes Cody Henderson, Brandyn Pokrass, Brandon Haye, Mackenzie Neglia, and more! There's also a guest appearance from broadcaster Daniel Tortora, formerly of ESPN and FOX Sports, who is host of The Wake Up Call with Dan Tortora.The League Winners are a company dedicated to covering the college football and the NFL. Created by Thomas Christopher, TLW was created to give football fans news, highlights, interviews, film review and much more surrounding the game of football.#USF #CollegeFootball #SouthFlorida #FAU #Maryland #FSU #Alabama #Auburn #Syracuse #CollegeFootballPodcast #CFB25 #CollegeFootball2025 #SyracuseOrange #FAUOwls #MarylandTerrapins #FSUSeminoles #AuburnTigers #FIU #FIUPanthers #USFBulls #LeagueWinners #Pitt #UCLA #Utah #Cal #CalFootball #CalGoldenBears

My life-changing annual event, The Summit of Greatness, is happening September 12 & 13, 2025. Get your ticket today!Check out the full episode: greatness.lnk.to/1814"The biggest lie I've been telling myself lately is that I've made it. I got to a point where I felt like I've kind of made it... but age is a number and I have more capital than I've ever had. I think I can still do it again." - Robert HerjavecHere's a man worth hundreds of millions, with private jets and luxury beyond most people's wildest dreams, sitting across from Lewis and admitting he's been living a lie. At 62, Robert Herjavec thought he could coast – that success meant he'd earned the right to slow down. But something shifted. He realized that all those material markers he'd chased, from the Corvette to the G4 to the G6 jet, were just distractions from the real question: Had he truly reached his potential? The vulnerability in his voice when he talks about wanting to feel on his deathbed that "I couldn't have done more" hits different when it comes from someone who seemingly has everything.What Robert reveals about redefining success will challenge everything you think you know about achievement. This isn't about accumulating more stuff or hitting bigger numbers – it's about the brutal honesty required to keep growing when the world tells you you've already won. His approach to handling criticism, leaving ego at the door, and finding fulfillment in the chaos of raising twins while still pursuing new ventures offers a masterclass in what it really means to live fully. If you've ever caught yourself thinking you've "arrived" or that your best days are behind you, this conversation will shake you awake.Sign up for the Greatness newsletter: http://www.greatness.com/newsletter

Recommending some of the most interesting games of the opening weekend, from an important G6 clash to Top Ten tilts. Sign up for the newsletter and/or browse the merch here: https://linktr.ee/rakesreport

Tonight we recap the GS-31 for the f2p who recently finished their 100 day journey on how it works and how to use the refinery, as well as what it pays, but the big revelation tonight comes in new Serene Squall research, loops, and refinery payouts.... Did we miss the biggest benefit of all for G6 players? IS this ship as influential as Monaveen was? or Revenant? JulesVern has the answers. 

Host Carter Yates and senior writer Mike Craven are joined by Jared Kalmus of the Alamo Audible to preview UTSA's 2025 season! (2:30 – 4:07) Did UTSA do enough in the backhalf of 2024 to get fans hyped for the 2025 season? (4:07 – 7:50) Why did UTSA take a step back in 2024? Did UTSA ever correct the dumb penalties? Was the lack of discipline in 2024 a blip on the radar, or a sign of something bigger? (7:50 – 9:20) Do we need to recalibrate what we judge as a great roster in G6 football? (9:20 – 12:00) Is Owen McCown the best returning QB in the American? Does UTSA have enough weapons around him? Who's a breakout star candidate? (12:00 – 14:50) Why Robert Henry is the bellcow back and the offensive line could be better in 2025. (14:50 – 16:45) Why is UTSA always injured? (16:45 – 20:00) Why defensive line is the one position group Jared thinks will be good no matter what (20:00 – 23:45) Why Shad Banks Jr is the most important player on the defense (23:45 – 27:00) Why Jared is iffy on the secondary? (27:00 – 30:15) Who is kicking for UTSA? How the portal has wrecked G6 kicking games. (30:15 – 33:20) Why do UTSA fans have the attitudes they do? (33:20 – END) Team MVP, X-Factor, Record Prediction Learn more about your ad choices. Visit megaphone.fm/adchoices

Host Carter Yates and senior writer Mike Craven break down all the biggest storylines in the G6 conferences this season. (INTRO – 14:25) Texas State. Are the Bobcats as talented as last year? How will new OC Landon Keopple do? (14:25 – 25:00) North Texas. Can UNT portal a dominant offense again? Will Skyler Cassity revive the defense? (25:00 – 34:40) UTSA. Did Jeff Traylor have the best quote in the summer magazine? (34:40 – 41`:50) Rice. This season hinges on Chase Jenkins. (41:50 – 51:25) Sam Houston. Is Phil Longo one of the most polarizing hires in the country? How big of a deal is not having a home stadium? (51:25 – End) UTEP. Is UTEP a sneaky 9 win bet? What the hell is happening with the QB room? Learn more about your ad choices. Visit megaphone.fm/adchoices

节目提要：1、为什么说G7最推荐的配置是Ultra版2、为什么说算力并不代表智驾能力3、三颗图灵芯片到底能做什么4、为什么说G6的价格必须下调 5、与华为合作的AR-HUD好不好用6、G7与G6预计竞品之间怎么选想与三刀1对1交流，扫码加入知识星球：

In today's episode, we cover how Trump will respond to the Irsael-Iran strikes, the G7 summit is reduced to G6 after Trump's premature departure, and Israeli tank fire kills 51 in Gaza waiting for aid.Watch TLDR's latest videos here:https://youtu.be/q9m2oa__Z0o?si=qDnqp0rCq4QAyyXT TLDR's Daily Briefing is a roundup of the day's most important news stories from around the world. But we don't just tell you what's happening, we explain it: making complex topics simple to understand. Listen to the Daily Briefing for your global news bulletin every weekday.Subscribe to TLDR's weekly newsletter here: https://toolong.news/newsletter Produced and edited by Scarlett WatchornHosted by Georgina FindlayWritten by Georgina Findlay and Rory TaylorMusic by Epidemic Sound: http://epidemicsound.com/creator//////////////////////////////Sources:✍️ How Will Trump Respond to the Israel-Iran War?https://on.ft.com/4kERAv7https://on.ft.com/3HKVWSJhttps://www.bbc.co.uk/news/articles/cx23e4pzjg3ohttps://www.bbc.co.uk/news/live/cx23e4jz2g0t✍️ Other G7 updateshttps://apnews.com/article/g7-summit-canada-trump-departure-ukraine-6c86a0a8463603c9b1a3e950382af0a2https://www.politico.eu/article/trump-slams-publicity-seeking-macron-amid-early-g7-exit/https://www.bbc.co.uk/news/articles/cy8gxp7dvepo ✍️ 51 Gazans Killed by Israeli Tank Firehttps://www.reuters.com/world/africa/kenyan-police-fire-teargas-protesters-after-death-blogger-custody-2025-06-17/https://apnews.com/article/israel-palestinians-hamas-war-news-gaza-aid-06-17-2025-7af5503ea7d2176674fba26d34f6ef74 See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

1. longstoryshort – DON'T DO IT 00:01:03 2. So Dope - MEANT2B 00:03:50 3. Torcha & skxllflower - Syndicate 00:05:42 4. DIGITAL ETHOS - GET BUSY 00:07:45 5. Arya - JA MAN! 00:10:57 6. Kaya - Canis Lupus 00:12:47 7. Dizzy! - Cantina 00:15:59 8. far east movement - like a G6 (saka flip) 00:19:11 9. Waka Flocka Flame ft. Kebo Gotti - Grove St. Party (Super Future Remix) 00:21:14 10. Chris Lake & Disclosure - in2minds 00:23:38 11. Zoey808 - DIAMONDzZz 00:26:09 12. Angrybaby - PUT IT DOWN (Jkyl & Hyde Remix) 00:28:54 13. Hydraulix x Robustt - Mash It Up! 00:31:45 14. Subject 31 - I'd Be Lion 00:33:35 15. Darby & Strobez - Lose My Mind 00:36:24 16. borne - Hold Me Down 00:38:01 17. BLOX - NEMESIS 00:39:51 18. Odd Language & Cozmoe - Brave This World 00:43:30 19. T & Sugah - Don't Stop 00:47:08 20. Teezy - The Rhythm 00:49:54 21. Zapya & Mad Sam - Run Di Area (MÆDM Remix) 00:53:35 22. Sustance - Cycles 00:56:20

Олег Саакян, політолог, на Radio NV про масштабний удар по ключових об'єктах ядерної програми Ірану, знищення ключових вчених та високих військовопосадовців, операцію Павутина в Ірані, про США, які відверто зливали свого союзника – Ізраїль та як він зірвав невигідну угоду з Іраном, про Трампа, який збирає екстрене засідання та яких заяв слід від нього очікувати, про мирні перемовини, які зайшли в глухий кут та що означають оптимістичні слова Кіта Келлога насправді, про беззаперечну перемогу України та як по нас вдарить те, що відбувається між Іраном та Ізраїлем, про поведінку США щодо Росії та чи будуть введені нові санкції проти Росії, які підготував Ліндсі Грем, а також про G7, які стали G6 плюс США та що означає привітання Марко Рубіо росіян з днем Росії.Ведуча – Інна Марецька

(00:00-13:34) Doug's always been an acorn fan. MLB attendance talk. Which organization has had the most growth and had the biggest drop year over year in attendance? Audio of David Samson of CBS breaking down Jac Caglianone's call up. Doug is DEV. Doug's unhappy with Peggy and Margaret.(13:42-26:51) Fly like a G6. Bar mitzvahs circa 2010. Audio of Chairman Kurt's statement yesterday regarding his filtering process for the EMOTD. Chairman says his love handles will be gone by his 40th birthday next month. D Day.(27:01-32:13) RHWOTMA would so do numbys. Seed round. Jackson can name all 50 state capitals. What's the most texted in picture ever into the text inbox.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

國泰世華 CUBE Podcast 節目「解鎖從容理財」由主持人小詹與證券投資分析師薯哥分享財經情勢與理財小故事的與你一起創造「從容投資、品味理財」的態度生活。立即收聽 ➡️ https://fstry.pse.is/7l4x2c —— 以上為 KKBOX 與 Firstory Podcast 廣告 —— 「PLG在打冠軍戰，你們怎麼都沒有討論？」類似的私訊，過去一周多次出現在小人物上籃社群信件夾中。其實有喔！小人物聽眾們應該有注意到每場賽後的會員特輯，現在EP.176全部集結一次公開，來回顧這系列台籃史上少有的7場打好打滿大決戰！ 這次PLG冠軍賽，Roy現場看了G2、G5，小枚看了G3、G7，兩位主持人的現場觀賽心得、加上Kong每場直播督軍、以及隔壁棚海神助教Sean期間的插花，小人物聽眾們可以跟著每場賽後討論既真實又及時的情緒起伏，回想戰況是如何發展到最後的搶七大戰、兩隊如何糾纏到第四節最後時刻。這個被許多球迷笑稱半前年就已經決定好的決賽隊戰組合，兩隊賽前做了哪些準備？期間做了哪些調整？每場賽後討論與預測，哪些有發生？哪些沒有？哪些出乎意料之外？！ 當橘色彩帶撒下，球賽的結局只有一隊能舉起冠軍盃，但能夠出現在這樣堪稱經典的系列賽的最終舞台，兩支球隊、全場球迷、看直播與聽節目的每一個人，一起成就並經歷過程的我們，都是贏家！ 成為

David, Ryan, and Tim talk about CFP expansion and their plans to sideline the G6, RJ Hunter becoming eligible for the Georgia State Hall of Fame, and more. Follow us Web: http://stateofatlanta.com Facebook: http://facebook.com/STATEofAtlanta Twitter: http://twitter.com/STATEofAtlanta SoundCloud: https://soundcloud.com/user-466493756 YouTube: https://www.youtube.com/@STATEofAtlanta Support the show Patreon: http://patreon.com/STATEofAtlanta Rock our swag Merch: http://merch.STATEofAtlanta.com

#755 Show Notes: https://wetflyswing.com/755  Presented by: Pescador on the Fly If you've ever tried to sneak in a little fly fishing on a business trip or family vacation, this episode is for you. Jeff Ditsworth of Pescador on the Fly shares his fly fishing travel hacks from 25+ years of experience. We dive into how to pack light, avoid common gear mistakes, and make the most of those bonus fishing hours. Jeff also gives us the lowdown on his G6 packable rod and why he always brings at least two rods on every trip. Whether you're headed to Montana or Mexico, you'll walk away with simple tricks to fish more and stress less. Show Notes: https://wetflyswing.com/755 

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: Learning more about the FDA letter sent to Dexcom, news from ATTD including a bihormonal pump from a Dutch company, time in tight range update, more studies about using insulin and GLP-1 medications, eating chili to prevent gestational diabetes (really!) and more..  Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom   Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links: Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX Our top story this week: Dexcom Dive Brief: A warning letter posted Tuesday by the Food and Drug Administration revealed quality control issues with Dexcom's continuous glucose monitors. The FDA raised concerns with a design change to a component used in the resistance layer of Dexcom's sensors. The sensors with the new component were less accurate than those with the original component, according to the warning letter. Dexcom has ceased distribution of G7 sensors with the component, but the company's response did not address affected G6 sensors. J.P. Morgan analyst Robbie Marcus wrote in a research note Tuesday that the letter concerns a chemical compound that the sensor wire is dipped in. Dexcom began producing the compound internally to add redundancy to its supply chain.   Dive Insight: Dexcom Chief Operating Officer Jake Leach said in an interview with MedTech Dive last week that the company does not expect the warning letter to affect future product approvals, including a 15-day version of its G7 CGM, and there's no need yet to recall products. Dexcom has submitted the device to the FDA and anticipates a launch in the second half of the year.   Marcus, after speaking to company leadership and a quality control expert, wrote that many of the issues outlined in the letter could be addressed quickly. He added that the warning letter could explain minor delays in approval to the 15-day sensor, but Dexcom is still within the 90-day window for a 510(k) submission.   “While there's always a risk this could impede future product approvals,” Marcus wrote, “we do not expect this to materially delay the 15 day G7 sensor approval.”   The warning letter followed an FDA inspection last year of Dexcom's facilities in San Diego and Mesa, Arizona. Marcus wrote that after the FDA requested additional information and a separate 510(k), Dexcom stopped in-sourcing the compound and reverted back to the external supplier.   Dexcom's devices were misbranded because the company did not submit a premarket notification to the FDA before making major changes to the sensors, according to the warning letter. The sensors with the changed coating “cause higher risks for users who rely on the sensors to dose insulin or make other diabetes treatment decisions,” the letter said.     The FDA raised other concerns in the warning letter, including procedures to monitor the glucose and acetaminophen concentrations used in testing of the G6 and G7 CGMs. The FDA also cited problems with Dexcom's handling last year of a deficiency in its G6 sensors with dissolved oxygen content values, a key input for measuring blood glucose levels. https://www.medtechdive.com/news/dexcom-warning-letter-cgm-coating-change/743597/ XX Lots of studies and info out of the recent ATTD conference. One highlight that has been sort of under the radar: a Dutch company has been using a Bihormonal fully closed-loop system for the treatment of type 1 diabetes in the real world. This is a company called Inreda (in-RAY-duh). The Inreda AP® is an automatic system (closed loop) and independently regulates the blood glucose level by administering insulin and glucagon. The AP5 is certified in Europe and is being used in multiple studies and projects. The AP®6 is currently under development. https://www.inredadiabetic.nl/en/discover-the-ap/ https://pubmed.ncbi.nlm.nih.gov/38443309/ XX Let's talk about time in tight range. If you follow me and diabetes connections on social, you likely saw a video I made about this – it blew up last week. If not.. time in range has been a metric for a short while now.. in 2019 there was a consensus report advising a goal of 70% of time in the 70-180 mg/dL range for most people with type 1 diabetes (T1D) and type 2 diabetes (T2D), with modifications for certain subgroups. Recently we've been hearing more about 70-140 mg/dL — for longer periods as “time in tight range (TiTR).” At ATTD there was more talk about calling that range TING, or “time in normal glycemia.     There's a great writeup that I'll link up from the great Miriam Tucker on Medscape about a debate that happened at ATTD. On March 22, 2025, two endocrinologists debated this question at the Advanced Technologies & Treatments for Diabetes (ATTD) 2025. Anders L. Carlson, MD, medical director of the International Diabetes Center (IDC), Minneapolis, took the positive side, while Jeremy Pettus, MD, assistant professor of medicine at the University of California San Diego, who lives with T1D himself, argued that it's too soon.   https://www.medscape.com/viewarticle/should-time-tight-range-be-primary-diabetes-goal-2025a100073q?form=fpf   XX Sequel Med Tech announces its twist pump will be firs paired with Abbott's FreeStyle Libre 3 Plus. The twist has FDA approval for ages 6 and up and is set to begin its commercial launch by the end of June. The pump—designed by inventor Dean Kamen's Deka Research & Development—also incorporates the FDA-cleared Tidepool Loop software program, to record CGM blood sugar readings, make predictions based on trends and adjust its background insulin levels accordingly. https://www.fiercebiotech.com/medtech/sequel-med-tech-connects-twiist-insulin-pump-abbotts-cgm-ahead-market-debut XX Dexcom's longer-lasting CGM sensor looks promising, based on study results presented at the conference. The trial showed that the new 15-day G7 system is slightly more accurate than the current G7. The accuracy of CGM can be measured using MARD (mean absolute relative difference), which shows the average amount a CGM sensor varies from your actual glucose levels (a lower number is better).  The 15-day G7 has a MARD value of 8.0%, about the same as the Abbott Freestyle Libre 3. The Dexcom G7 15 Day is awaiting FDA approval and is not yet available in the U.S.   XX Little bit of news from Modular Medical.. they plan to submit their patch pump to the FDA late summer or fall of this year. The MODD1 product, a 90-day patch pump, features new microfluidics technology to allow for the low-cost pumping of insulin. Its new intuitive design makes the product simple to use and easier to prescribe. It has a reservoir size of 300 units/3mL. Users can monitor the pump activity with their cell phone and do not require an external controller. The pump uses a provided, single-use, disposable battery. Modular Medical picked up FDA clearance for MODD1 in September. The company also raised $8 million to end 2024. Its founder, Paul DiPerna, previously founded leading insulin pump maker Tandem Diabetes Care. DiPerna invented and designed Tandem's t:slim pump. By developing its patented insulin delivery technologies, the company hopes to improve access to glycemic control. Its founder, Paul DiPerna, previously founded leading insulin pump maker Tandem Diabetes Care. DiPerna invented and designed Tandem's t:slim pump. https://www.drugdeliverybusiness.com/modular-medical-announces-12m-private-placement/ XX More from attd – type 2 news? https://www.drugdeliverybusiness.com/biggest-diabetes-tech-news-attd-2025/ XX Another study that says people with type 1 who use a GLP-1 medication get better outcomes. In this study, those who use GLP-1 with insulin are 55% less likely to have a hyperglycemia-related ED visit, 26% less likely to have an amputation-related visit, and 29% less likely to have a diabetic ketoacidosis (DKA)-related ED visit in the following year compared to those on insulin alone. Although they are not approved for T1D, some patients may receive them off-label or for weight control. Pretty big study for an off label drug: compared 7,010 adult patients with T1D who were prescribed GLP-1s and insulin to 304,422 adult patients with T1D who were on insulin alone.  It is important to note that the rates of new diabetic complications in one year for both groups were around 1%, indicating that these are uncommon outcomes regardless of medication use. https://www.epicresearch.org/articles/some-diabetic-complications-less-likely-among-type-1-diabetics-on-glp-1s   XX Early research here but exposure to antibiotics during a key developmental window in infancy may stunt the growth of insulin-producing cells in the pancreas and boost risk of diabetes later in life The study, is published this month in the journal Science, it's a study in mice. These researchers are working off the idea that when while identical twins share DNA that predisposes them to Type 1 diabetes, only one twin usually gets the disease. She explained that human babies are born with a small amount of pancreatic “beta cells,” the only cells in the body that produce insulin.   But some time in a baby's first year, a once-in-a-lifetime surge in beta cell growth occurs.   “If, for whatever reason, we don't undergo this event of expansion and proliferation, that can be a cause of diabetes,” Hill said.   They found that when they gave broad-spectrum antibiotics to mice during a specific window (the human equivalent of about 7 to 12 months of life), the mice developed fewer insulin producing cells, higher blood sugar levels, lower insulin levels and generally worse metabolic function in adulthood.   in other experiments, the scientists gave specific microbes to mice, and found that several they increased their production of beta cells and boosted insulin levels in the blood. When male mice that were genetically predisposed to Type 1 diabetes were colonized with the fungus in infancy, they developed diabetes less than 15% of the time. Males that didn't receive the fungus got diabetes 90% of the time. Even more promising, when researchers gave the fungus to adult mice whose insulin-producing cells had been killed off, those cells regenerated. Hill stresses that she is not “anti-antibiotics.” But she does imagine a day when doctors could give microbe-based drugs or supplements alongside antibiotics to replace the metabolism-supporting bugs they inadvertently kill.   .   “Historically we have interpreted germs as something we want to avoid, but we probably have way more beneficial microbes than pathogens,” she said. “By harnessing their power, we can do a lot to benefit human health.”     https://www.eurekalert.org/news-releases/1078112 XX Future watch for something called BeaGL - created by researchers at the University of California Davis and UC Davis Health who were inspired by their own personal experiences with managing T1D.   BeaGL is designed to work with CGMs and has security-focused machine learning algorithms to make predictive alerts about anticipated glucose changes, which are sent to a device. In this case, a smartwatch. The end goal is for BeaGL to be completely automated to reduce the cognitive load on the patient, particularly for teens. It's still in research phase but six student with T1D have been using it for almost a year.     https://health.ucdavis.edu/news/headlines/with-ai-a-new-metabolic-watchdog-takes-diabetes-care-from-burden-to-balance/2025/02 XX Investigators are searching for a way forward after two long-term diabetes programs were terminated following the cancellation of their National Institutes of Health (NIH) funding, the result of federal allegations that study coordinator Columbia University had inappropriately handled antisemitism on campus. The programs include the three-decades-old Diabetes Prevention Program (DPP) and its offshoot, the Diabetes Prevention Program Outcomes Study (DPPOS). “We are reeling,” said David Nathan, MD, a previous chair of both the DPP and the DPPOS and an original leader of the landmark Diabetes Control and Complications Trial. Nathan is also founder of the Massachusetts General Hospital Diabetes Center in Boston, one of the 30 DPPOS sites in 21 states. On March 7, the Trump administration cancelled $400 million in awards to Columbia University from various federal agencies. While Columbia University agreed on March 21 to changes in policies and procedures to respond to the Trump administration's charges, in the hopes that the funding would be restored, DPPOS Principal Investigator Jose Luchsinger, MD, told Medscape Medical News that as of press time, the study was still cancelled. https://www.medscape.com/viewarticle/diabetes-prevention-program-cancellation-colossal-waste-2025a100076h XX XX Type 2 diabetes may quietly alter the brain in ways that mimic early Alzheimer's. This was only an animal study – but researchers say the high comorbidity of type 2 diabetes (T2D) with psychiatric or neurodegenerative disorders points to a need for understanding what links these diseases.   https://scitechdaily.com/how-diabetes-quietly-rewires-the-brains-reward-and-memory-system/ XX Eating chili once a month when you're pregnant seems to lower the risk of developing gestational diabetes. This is a real study! While chili showed a link to lower gestational diabetes risk, dried beans and bean soup had no significant effect, even among women who ate them more frequently. Some studies suggest that diets high in beans and legumes, including the Mediterranean diet, reduce GDM risk. While studies link beans to lower diabetes risk, their specific impact on GDM remains unclear. This study analyzed data from 1,397 U.S. pregnant women who participated in the Infant Feeding Practices Study II, conducted between 2005 and 2007. Chili consumption varied significantly by race, education, household size, income, supplemental nutrition status, and region. Non-Hispanic Black mothers consumed the most (0.33 cups/week), while those with higher income and education levels consumed less. Regional differences also influenced chili intake. One possible mechanism for chili's effect is capsaicin, a bioactive compound found in chili peppers, which has been linked to metabolic benefits in other studies. However, further research is needed to confirm this potential role in GDM prevention. Dried bean and bean soup consumption had no clear association with GDM. The study highlights limitations due to self-reported dietary data and the need for more detailed dietary measures. https://www.news-medical.net/news/20250317/Could-a-little-spice-in-your-diet-prevent-gestational-diabetes.aspx XX